Clinical Trial Update: Effect of Transjugular Intrahepatic Portosystemic Shunt on Gut Microbiota in Cirrhotic Patients

View source ↗

Summary

This clinical trial update describes the investigation of the Transjugular Intrahepatic Portosystemic Shunt (TIPS) and its effect on gut microbiota in patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatic Encephalopathy

Snippet

Sponsor: West China Hospital | Conditions: Cirrhosis, Acquired Portal-systemic Shunt Due to Cirrhosis | Status: UNKNOWN